Hematological disorders in children with Down syndrome.

Silvia TriaricoGiovanna TrombatoreMichele Antonio CapozzaAlberto RomanoStefano MastrangeloGiorgio AttinàPalma MauriziAntonio Ruggiero

Published in: Expert review of hematology (2022)

In contrast to the excellent prognosis of ML-DS obtained likewise with low doses of chemotherapy, DS-ALL patients show worse outcomes than non-DS children, therefore advances and risk-stratified treatment adjustments are mandatory for this particular set of patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
young adults
peritoneal dialysis
type diabetes
squamous cell carcinoma
skeletal muscle
patient reported
smoking cessation